US tax policy changes see doubling of key pharma roles

Pharmaceutical process development roles have doubled in Ireland thanks to shifts in US tax policies and other external drivers, according to NUI Maynooth economic geographer Chris van Egeraat.

Dr van Egeraat told overseas academics attending an economic conference yesterday in Maynooth that Ireland’s jump from 400 to 800 process development roles was impressive.

This 100% high-end gain compares to 35% total employment growth for the 76 pharma firms in his 2000 to 2006 study period.